EsopH is an acid reflux therapy gel that works to quickly provide relief from heartburn and discomfort, offer musosal protection, reduce inflammation, and help heal the esophageal mucosa.
It works by using hyaluronic acid to coat the esophageal mucosa to reduce the contact of refluxed acid and pepsin, as well as chondroitin sulphate, which helps with wound repair, cell regeneration, and reducing inflammation. Lastly, the Poloxamer 407 formula functions as a bioadhesive carrier "that prolongs the contact time of chondroitin sulphate and hyaluronic acid with esophageal mucosa."
The single-use liquid gel packs are easy to pack for relief on-the-go, and can be taken orally up to four times a day on an as-needed basis. EsopH is available for purchase without a prescription from pharmacy counters.
What's Driving This Trend
- Acid Reflux Therapy Gels
- EsopH can pave the way for more convenient and fast-acting solutions for GERD
- Hyaluronic Acid-coating Technology
- The use of hyaluronic acid for mucosal coating can spur innovation in drug delivery for gastrointestinal disorders
- Bioadhesive Carriers
- Poloxamer 407's ability as a bioadhesive carrier can lead to advancements in targeted drug delivery
Who This Affects Most
- Pharmaceuticals
- The development of acid reflux therapy gels can create new opportunities for the pharmaceutical industry in the gastroenterology market
- Healthcare
- This technology can improve healthcare management by providing more comfortable treatment options with improved patient outcomes
- Consumer Goods
- EsopH's convenient packaging can inspire advancements in over-the-counter (OTC) medications for acid reflux relief, causing a shift in consumer purchase preferences
